Erratum to Impact of anti-apoptotic and anti-oxidative effects of bone marrow mesenchymal stem cells with transient overexpression of heme oxygenase-1 on myocardial ischemia(Am J Physiol Heart Circ Physiol, (2010), 298, (H1320-H1329), 10.1152/ajpheart.01330.2008);Impact of anti-apoptotic and anti-oxidative effects of bone marrow mesenchymal stem cells with transient overexpression of heme oxygenase-1 on myocardial ischemia

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 298, Issue 5, 2010, Pages

  Tsubokawa, Toshinari ^a   Yagi, Kunimasa ^a   Nakanishi, Chiaki ^a   Zuka, Masahiko ^b   Nohara, Atsushi ^a   Ino, Hidekazu ^a   Fujino, Noboru ^a   Konno, Tetsuo ^a   Kawashiri, Masa Aki ^a   Ishibashi Ueda, Hatsue ^c   Nagaya, Noritoshi ^c   Yamagishi, Masakazu ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b Showa University   (Japan)

^c NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Apoptosis; Cell transplantation; Heme oxygenase 1; Mesenchymal stem cells; Myocardial ischemia

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; DEOXYURIDINE TRIPHOSPHATE PYROPHOSPHATASE; HEME OXYGENASE 1; HYDROGEN PEROXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; VASCULOTROPIN; WORTMANNIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BONE MARROW; CAPILLARY DENSITY; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; ECHOCARDIOGRAPHY; HEART INFARCTION SIZE; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HUMAN; HYPOXIA; IN VITRO STUDY; MALE; MATERNAL DEPRIVATION; MESENCHYMAL STEM CELL; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 77951868977     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.zh4-0507-corr.2012     Document Type: Erratum

References (49)

1. Assmus B, Schächinger V, Teupe C, Britten M, Lehmann R, Döbert N, Grünwald F, Aicher A, Urbich C, Martin H, Hoelzer D, Dimmeler S, Zeiher AM. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 106: 3009-3017, 2002. (Pubitemid 35440281)
2. Barbash IM, Chouraqui P, Baron J, Feinberg MS, Etzion S, Tessone A, Miller L, Guetta E, Zipori D, Kedes LH, Kloner RA, Leor J. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation 108: 863-868, 2003. (Pubitemid 37022130)
3. Berzi C, Rota M, Hosoda T, Tillmanns J, Nascimbene A, De Angelis A, Quaini F, Urbanek K, Michler RE, Bolli R, Kajstura J, Leri A, Anversa P. Human cardiac stem cells. Proc Natl Acad Sci USA 104: 14068-14073, 2007.
4. Bonnell MR, Visner GA, Zander DS, Mandalapu S, Kazemfar K, Spears L, Beaver TM. Heme-oxygenase-1 expression correlates with severity of acute cellular rejection in lung transplantaion. J Am Coll Surg 198: 945-952, 2004. (Pubitemid 38759846)
5. Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, Joyal SV, Hill KA, Pfeffer MA, Skene AM. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 350: 1495-1504, 2004.
6. Chen Y, Amende I, Hampton TG, Yang Y, Ke Q, Min JY, Xiao YF, Morgan JP. Vascular endothelial growth factor promotes cardiomyocyte differentiation of embryonic stem cells. Am J Physiol Heart Circ Physiol 291: H1653-H1658, 2006. (Pubitemid 44497669)
7. Choi AM. Heme oxygenase-1 protects the heart. Circ Res 89: 105-107, 2001.
8. Choi BM, Kim BR. Upregulation of heme oxygenase-1 by brazilin via the phosphatidylinositol 3-kinase/Akt and ERK pathways and its protective effect against oxidative injury. Eur J Parmacol 580: 12-18, 2008.
9. Coito AJ, Buelow R, Shen XD, Amersi F, Moore C, Volk HD, Busuttil RW, Kupiec Weglinski JW. Heme oxygenase-1 gene transfer inhibits inducible nitric oxide synthase expression and protects genetically fat Zucker rat livers from ischemia-reperfusion injury. Transplantation 74: 96-102, 2002. (Pubitemid 34779218)
10. Dai W, Hale SL, Martin BJ, Kuang JQ, Dow JS, Wold LE, Kloner RA. Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation 112: 214-223, 2005. (Pubitemid 40982304)
11. Dai W, Hale SL, Kloner RA. Role of a paracrine action of mesenchymal stem cells in the improvement of left ventricular function after coronary artery occlusion in rats. Regen Med 2: 63-68, 2007. (Pubitemid 46824413)
12. Dohi T, Miyauchi K, Okazaki S, Yokoyama T, Yanagisawa N, Tamura H, Kojima T, Yokoyama K, Kurata T, Daida H. Early intensive statin treatment for six months improves long-term clinical outcomes in patients with acute coronary syndrome (Extended-ESTABLISH trial): a follow-up study. Atherosclerosis 2: 63-68, 2009.
13. Fernández-Avilés F, San Román JA, García-Frade J, Fernández ME, Peñarrubia MJ, de la Fuente L, Gómez-Bueno M, Cantalapiedra A, Fernández J, Gutierrez O, Sánchez PL, Hernández C, Sanz R, García- Sancho J, Sánchez A. Experimental and clinical regeneration capability of human bone marrow cells after myocardial infarction. Circ Res 95: 742-748, 2004. (Pubitemid 39331935)
14. Fernandez M, Bonkovsky HL. Vascular endothelial growth factor increases heme oxygenase-1 protein expression in the chick embryo chorioallantoic membrane. Br J Pharmacol 139: 634-640, 2003. (Pubitemid 36819633)
15. Fraser JK, Zhu M, Wulur I, Alfonso Z. Adipose-derived cells. Methods Mol Biol 449: 59-67, 2008.
16. Fujii T, Nagaya N, Iwase T, Murakami S, Miyahara Y, Nishigami K, Ishibashi-Ueda H, Shirai M, Itoh T, Ishino K, Sano S, Kangawa K, Mori H. Adrenomedullin enhances therapeutic potency of bone marrow transplantation for myocardial infarction in rats. Am J Physiol Heart Circ Physiol 288: H1444-H1450, 2005. (Pubitemid 40270056)
17. Geraldes P, Yagi K, Ohshiro Y, He Z, Maeno Y, Yamamoto-Hiraoka J, Rask-Madsen C, Chung SW, Perrella MA, King GL. Selective regulation of heme oxygenase-1 expression and function by insulin through IRS1/Phoshoinositide 3-kinase/Akt-2 pathway. J Biol Chem 283: 34327-34336, 2008.
18. Hellgren I, Drvota V, Pieper R, Enoksson S, Blomberg P, Islam KB, Sylvén C. Highly efficient cell-mediated gene transfer using non-viral vectors and FuGene6: in vitro and in vivo studies. Cell Mol Life Sci 57: 1326-1333, 2000. (Pubitemid 30663487)
19. Hsu M, Muchova L, Morioka I, Wong RJ, Schröder H, Stevenson DK. Tissue-specific effects of statins on the expression of heme oxygenase-1 in vivo. Biochem Biophys Res Commun 343: 738-744, 2006.
20. Janssens S, Dubois C, Bogaert J. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 367: 113-121, 2006. (Pubitemid 43077127)
21. Jo J, Nagaya N, Miyahara Y, Kataoka M, Harada-Shiba M, Kangawa K, Tabata Y. Transplantation of genetically engineered mesenchymal stem cells improves cardiac function in rats with myocardial infarction: benefit of a novel nonviral vector, cationized dextran. Tissue Eng 13: 313-322, 2007. (Pubitemid 46273094)
22. Józkowicz A, Huk I, Nigisch A, Weigel G, Dietrich W, Motterlini R, Dulak J. Heme oxygenase and angiogenic activity of endothelial cells. Antioxid Redox Signal 5: 155-162, 2003.
23. Jujo K, Ii M, Losordo DW. Endothelial progenitor cells in neovascularization of infarcted myocardium. J Mol Cell Cardiol 45: 530-544, 2008.
24. Katavetin P, Inagi R, Miyata T, Shao J, Sassa R, Adler S, Eto N, Kato H, Fujita T, Nangaku M. Erythropoietin induces heme oxygenase-1 expression and attenuates oxidative stress. Biochem Biophys Res Commun 359: 928-934, 2007. (Pubitemid 46946906)
25. Katori M, Tamaki T, Takahashi T, Tanaka M, Kawamura A, Kakita A. Prior induction of heat shock proteins by a nitric oxide donor attenuates cardiac ishemia/reperfusion injury in the rat. Transplantation 69: 2530-2537, 2000. (Pubitemid 30482018)
26. Kiefer K, Clement J, Garidel P, Peschka-Süss R. Transfection efficiency and cyotoxicity of nonviral gene transfer reagents in human smooth muscle and endothelial cells. Rharm Res 21: 1009-1017, 2004. (Pubitemid 38870152)
27. Lee TS, Chang CC, Zhu Y, Shyy JY. Simvastatin induces heme oxygenase-1: a novel mechanism of vessel protection. Circulation 110: 1296-1302, 2004. (Pubitemid 39202348)
28. Luo Z, Diaco M, Murohara T, Ferrara N, Inser JM, Symes JF. Vascular endothelial growth factor attenuates myocardial ischemia-reperfusion injury. Ann Thorac Surg 64: 993-998, 1997. (Pubitemid 27497373)
29. Mangi AA, Noiseux N, Kong D, He H, Rezvani M, Ingwall JS, Dzau VJ. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 9: 1195-1201, 2003. (Pubitemid 37173705)
30. Miyahara Y, Nagaya N, Kataoka M, Yanagawa M, Tanaka K, Hao H, Ishino K, Ishida H, Shimizu T, Kangawa K, Sano S, Okano T, Kitamura S, Mori H. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med 12: 459-465, 2006.
31. Nagaya N, Fujii T, Iwase T, Ohgushi H, Itoh T, Uematsu M, Yamagishi M, Mori H, Kangawa K, Kitamura S. Intravenous administration of mesenchymalstem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. Am J Physiol Heart Circ Physiol 287: H2670-H2676, 2004. (Pubitemid 39557139)
32. Nagaya N, Kangawa K, Itoh T, Iwase T, Murakami S, Miyahara Y, Fujii T, Uematsu M, Ohgushi H, Yamagishi M, Tokudome T, Mori H, Miyatake K, Kitamura S. Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 112: 1128-1135, 2005. (Pubitemid 41216119)
33. Nagaya N, Shimizu W, Yamagishi M, Noguchi T, Ohnishi K, Kitakaze M, Tomoike H, Kitamura S. Clinical trial of autologus bone marrow mesenchymal stem cell transplantaion for severe chronic heart failure (Abstract). Circulation Suppl 116: 453, 2007.
34. Nakanishi C, Yamagishi M, Yamahara K, Hagino I, Mori H, Sawa Y, Yagihara T, Kitamura S, Nagaya N. Activation of cardiac progenitor cells through paracrine effects of Mesenchymal stem cells. Biochem Biophys Res Commun 374: 11-16, 2008.
35. Oswald J, Boxberger S, Jorgensen B, Feldmann S, Ehninger G, Bornhäuser M, Werner C. Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells 22: 377-384, 2004. (Pubitemid 38736621)
36. Otterbein LE, Bach FH, Alam J, Soares M, Tao Lu H, Wysk M, Davis RJ, Flavell RA, Choi AM. Carbone monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 6: 422-428, 2000. (Pubitemid 30208159)
37. Otterbein LE, Choi AM. Heme oxygenase: colors of defense against cellular stress. Am J Physiol Lung Cell Mol Physiol 279: L1029-L1037, 2000.
38. Pachori AS, Smith A, MacDonald P, Zhang L, Dzau VJ, Melo LG. Heme-oxygenase-1 induced protection against hypoxia/reoxygenation is dependent on biliverdin reductase and its interaction with PI3/Akt pathway. J Mol Cell Cardiol 43: 580-592, 2007. (Pubitemid 47615045)
39. Pileggi A, Molano RD, Berney T, Cattan P, Vizzardelli C, Oliver R, Fraker C, Ricordi C, Pastori RL, Bach FH, Inverardi L. Hemeoxygenase- 1 induction in islet cells results in protection from apoptosis and improved in vivo function after transplantation. Diabetes 50: 1983-1991, 2001.
40. Shibahara S, Yoshizawa M, Suzuki H, Takeda K, Meguro K, Endo K. Functional analysis of cDNA for two types of human heme oxygenase and evidence for their separate regulation. J Biochem 113: 214-218, 1993. (Pubitemid 23081856)
41. Shiojima I, Walsh K. Role of Akt signaling in vascular homeostasis and angiogenesis. Circ Res 90: 1243-1250, 2002. (Pubitemid 34787405)
42. Stamm C, Westphal B, Kleine HD, Petzsch M, Kittner C, Klinge H, Schümichen C, Nienaber CA, Freund M, Steinhoff G. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 361: 45-46, 2003. (Pubitemid 36050962)
43. Tang YL, Tang Y, Zhang YC, Qian K, Shen L, Phillips MI. Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. J Am Coll Cardiol 46: 1339-1350, 2005. (Pubitemid 41615559)
44. Tsao YP, Ho TC, Chen SL, Cheng HC. Pigment epithelium-derived factor inhibits oxidative stress-induced cell death by activation of extracellular signal-regulated kinases in cultured retinal pigment epithelial cells. Life Sci 79: 545-550, 2006. (Pubitemid 43913210)
45. Urbanek K, Torella D, Sheikh F, De Angelis A, Nurzynska D, Silvestri F, Beltrami CA, Bussani R, Beltrami AP, Quaini F, Bolli R, Leri A, Kajstura J, Anversa P. Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proc Natl Acad Sci USA 102: 8692-8697, 2005. (Pubitemid 40862797)
46. Yamashita K, Ollinger R, McDaid J, Sakahama H, Wang H, Tyagi S, Csizmadia E, Smith NR, Soares MP, Bach FH. Heme oxygenase-1 is essential for and promotes tolerance to transplanted organs. FASEB J 20: 776-778, 2006. (Pubitemid 46671212)
47. Yet SF, Tian R, Layne MD, Wang ZY, Maemura K, Solovyeva M, Ith B, Melo LG, Zhang L, Ingwall JS, Dzau VJ, Lee ME, Perrella MA. Cardiac-specific expression of heme oxygenase-1 protects against ischmic and reperfusion injury in transgenic mice. Circ Res 89: 168-173, 2001. (Pubitemid 34135825)
48. Zhang M, Methot D, Poppa V, Fujino Y, Walsh K, Murry CE. Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J Mol Cell Cardiol 33: 907-921, 2001. (Pubitemid 32545326)
49. Zhu W, Chen J, Cong X, Hu S, Chen X. Hypoxia and serum deprivation- induced apoptosis in mesenchymal stem cells. Stem Cells 24: 416-425, 2006. (Pubitemid 44464811)